Assembly Biosciences, Inc. Interest Expense, Other
Assembly Biosciences, Inc. (ASMB) reported Interest Expense, Other of $0 for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-14.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseOther · last filed 2014-05-14
- Assembly Biosciences, Inc. interest expense, other for the quarter ending 2014-03-31 was $0.00.
- Assembly Biosciences, Inc. interest expense, other for the quarter ending 2013-09-30 was $0.00.
- Assembly Biosciences, Inc. interest expense, other for the quarter ending 2013-06-30 was $0.00.
- Assembly Biosciences, Inc. interest expense, other for the quarter ending 2013-03-31 was $0.00.
- Assembly Biosciences, Inc. interest expense, other for fiscal 2013 was $0.00.
- Assembly Biosciences, Inc. interest expense, other for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- Assembly Biosciences, Inc. interest expense, other for fiscal 2011 was $116.66K, a 94.29% decline from fiscal 2010.
- Assembly Biosciences, Inc. interest expense, other for fiscal 2010 was $2.04M.
| Period end | Interest Expense, Other 3 month | Interest Expense, Other 6 month | Interest Expense, Other 9 month | Interest Expense, Other 12 month | Interest Expense, Other 72 month | Interest Expense, Other 81 month | Interest Expense, Other 84 month | Interest Expense, Other 87 month | Interest Expense, Other 90 month | Interest Expense, Other 93 month | Interest Expense, Other 96 month | Interest Expense, Other 99 month | Interest Expense, Other 102 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $0.00 10-Q · filed 2014-05-14 | $4.98M 10-Q · filed 2014-05-14 | |||||||||||
| 2013-12-31 | $0.00 10-K · filed 2014-03-31 | $4.98M 10-K · filed 2014-03-31 | |||||||||||
| 2013-09-30 | $0.00 10-Q · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $4.98M 10-Q · filed 2013-11-12 | ||||||||
| 2013-06-30 | $0.00 10-Q · filed 2013-08-09 | $0.00 derived: sum of 2 quarters · filed 2014-05-14 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $4.98M 10-Q · filed 2013-08-09 | ||||||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 2 quarters · filed 2014-05-14 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $4.98M 10-Q · filed 2013-05-10 | ||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $0.00 derived: sum of 2 quarters · filed 2014-03-31 | $0.00 derived: sum of 3 quarters · filed 2014-03-31 | $0.00 10-K · filed 2014-03-31 | $4.98M 10-K · filed 2013-03-18 | ||||||||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $0.00 10-Q · filed 2012-11-13 | $0.00 derived: sum of 4 quarters · filed 2013-11-12 | $4.98M 10-Q · filed 2012-11-13 | ||||||||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-09 | $0.00 derived: sum of 2 quarters · filed 2013-08-09 | $0.00 derived: sum of 3 quarters · filed 2013-08-09 | $30.61K derived: sum of 4 quarters · filed 2013-08-09 | $4.98M 10-Q · filed 2012-08-09 | ||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-10 | $0.00 derived: sum of 2 quarters · filed 2013-05-10 | $30.61K derived: sum of 3 quarters · filed 2013-05-10 | $72.00K derived: sum of 4 quarters · filed 2013-05-10 | |||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $30.61K derived: sum of 2 quarters · filed 2013-03-18 | $72.00K derived: sum of 3 quarters · filed 2013-03-18 | $116.66K 10-K · filed 2013-03-18 | |||||||||
| 2011-09-30 | $30.61K 10-Q · filed 2012-11-13 | $72.00K derived: sum of 2 quarters · filed 2012-11-13 | $116.66K 10-Q · filed 2012-11-13 | $4.98M 10-Q/A · filed 2011-11-18 | |||||||||
| 2011-06-30 | $41.40K 10-Q · filed 2012-08-09 | $86.06K 10-Q · filed 2012-08-09 | |||||||||||
| 2010-12-31 | $223.05K derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-18 | $909.14K derived: sum of 2 quarters · filed 2013-03-18 | $2.04M 10-K · filed 2013-03-18 | ||||||||||
| 2010-09-30 | $686.09K 10-Q/A · filed 2011-11-18 | $1.82M 10-Q/A · filed 2011-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |